Nephro Care India Limited (NSE:NEPHROCARE)

India · Delayed Price · Currency is INR

89.50

+2.60 (2.99%)

At close: Aug 21, 2026

-34.46% (1Y)

Market Cap	1.48B -34.5%
Revenue (ttm)	1.01B +84.5%
Net Income	56.25M +196.3%
EPS	3.42 +186.8%
Shares Out	16.49M
PE Ratio	26.19
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	28,400
Open	90.00
Previous Close	86.90
Day's Range	87.00 - 91.20
52-Week Range	50.05 - 183.00
Beta	1.45
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Nephro Care India

Nephro Care India Limited, provides treatment for kidney-related diseases in India. The company offers care for renal failure patients that include consultation, treatment, and yoga; nutritional support, including nutritional support for weight loss/weight gain, body composition analysis, anthropometry, and lifestyle education and support services for diabetic kidney disease, hypertensive nephropathy, glomerular disease, renal transplant recipient, hemodialysis patient, IgA nephropathy, lupus nephropathy, and ADPKD; and lifestyle and rehabilita... [Read more]

Industry Hospitals

Founded 2014

Employees 334

Stock Exchange National Stock Exchange of India

Ticker Symbol NEPHROCARE

Full Company Profile

Financial Performance

In fiscal year 2026, Nephro Care India's revenue was 887.35 million, an increase of 92.77% compared to the previous year's 460.31 million. Earnings were 33.69 million, a decrease of -7.42%.

Financial Statements